A detailed history of Cowa, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cowa, LLC holds 5,457 shares of ABBV stock, worth $1.08 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
5,457
Previous 5,457 -0.0%
Holding current value
$1.08 Million
Previous $994 Million 5.81%
% of portfolio
0.5%
Previous 0.59%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$159.82 - $182.1 $31,964 - $36,420
-200 Reduced 3.54%
5,457 $994 Million
Q4 2023

Jan 16, 2024

SELL
$137.6 - $154.97 $27,520 - $30,994
-200 Reduced 3.41%
5,657 $877 Million
Q3 2023

Oct 30, 2023

SELL
$133.59 - $154.65 $26,718 - $30,930
-200 Reduced 3.3%
5,857 $873 Million
Q2 2023

Jul 25, 2023

BUY
$132.51 - $164.9 $26,502 - $32,980
200 Added 3.41%
6,057 $816 Million
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $28,922 - $33,308
-200 Reduced 3.3%
5,857 $933,000
Q3 2022

Nov 04, 2022

SELL
$134.21 - $153.93 $54,086 - $62,033
-403 Reduced 6.24%
6,057 $813,000
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $25,046 - $31,842
-182 Reduced 2.74%
6,460 $989,000
Q1 2022

May 18, 2022

SELL
$131.98 - $163.75 $86.8 Million - $108 Million
-657,629 Reduced 99.0%
6,642 $1.08 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $86.8 Million - $108 Million
657,337 Added 9479.91%
664,271 $1.08 Million
Q4 2021

Feb 04, 2022

SELL
$107.43 - $135.93 $23,956 - $30,312
-223 Reduced 3.12%
6,934 $939,000
Q3 2021

Oct 22, 2021

SELL
$106.4 - $120.78 $11,491 - $13,044
-108 Reduced 1.49%
7,157 $772,000
Q2 2021

Aug 02, 2021

SELL
$105.21 - $117.21 $10,415 - $11,603
-99 Reduced 1.34%
7,265 $830,000
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $116,622 - $128,386
1,140 Added 18.32%
7,364 $792,000
Q4 2020

Feb 05, 2021

BUY
$80.49 - $108.67 $500,969 - $676,362
6,224 New
6,224 $698,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $349B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cowa, LLC Portfolio

Follow Cowa, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowa, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowa, LLC with notifications on news.